Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 nov. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics Initiates Phase I Clinical Trial of CH-4051

CHARLOTTE, N.C., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has begun dosing volunteers in the single ascending dose (SAD) study of its Phase I clinical...
12 nov. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Analyst and Institutional Investor Day in New York

CHARLOTTE, N.C., Nov. 12, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) will be hosting its 2008 analyst and institutional investor day from 9:30 AM to 12:00 PM on...
05 nov. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Third Quarter 2008 Results

CHARLOTTE, N.C., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the third quarter 2008. Chelsea's management team will...
03 nov. 2008 07h00 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Significant Reduction in Severity of Symptoms During Titration Phase of Pivotal Droxidopa Study in Neurogenic Orthostatic Hypotension

* Responders Demonstrated Mean Reduction in Symptomatic Score of 4.6 Units and Increase of 27mmHg in Standing Systolic Blood Pressure CHARLOTTE, N.C., Nov. 3, 2008 (GLOBE NEWSWIRE) --...
30 oct. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At the Rodman and Renshaw 10th Annual Healthcare Conference On Monday, November 10, 2008

CHARLOTTE, N.C., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference at 3:40...
29 oct. 2008 07h25 HE | Source: Chelsea Therapeutics

Data From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 19th Annual International Symposium on the Autonomic Nervous System

CHARLOTTE, N.C., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that Horacio Kaufmann, M.D. will present initial data from the open-label portion of...
28 oct. 2008 07h25 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics Completes Enrollment in Phase II Trial of CH-1504 in Rheumatoid Arthritis

CHARLOTTE, N.C., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has completed patient enrollment in its Phase II trial comparing the...
27 oct. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2008 Results

CHARLOTTE, N.C., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release third quarter results for the period ended September 30, 2008...
21 oct. 2008 07h30 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics Announces Positive DSMB Recommendation for CH-1504 Phase II Trial in Rheumatoid Arthritis

CHARLOTTE, N.C., Oct. 21, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that an independent Data Safety Monitoring Board (DSMB) recently met to review...
20 oct. 2008 08h25 HE | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At the Oppenheimer 19th Annual Healthcare Conference On Tuesday, November 4, 2008

CHARLOTTE, N.C., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Oppenheimer 19th Annual Healthcare Conference at 10:40 AM on...

Page précédente